Mechanism of action of hypotensive prostaglandins in patients with essential hypertension

Journal of Smooth Muscle Research

Volumn 38, Issue 3, 2002, Pages 51-61

  Michibayashi, Tsutomu ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Essential hypertension; Hypotensive prostaglandins; Noradrenaline; Perivascular sympathetic nerve

Indexed keywords

ANGIOTENSIN; NORADRENALIN; PROSTAGLANDIN;

ADRENERGIC TRANSMISSION; ADULT; ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; ESSENTIAL HYPERTENSION; HUMAN; MALE; NONHUMAN; PATHOGENESIS; PROSTAGLANDIN METABOLISM; PROTEIN FUNCTION; RABBIT; SYMPATHETIC NERVE; VASOCONSTRICTION;

ADULT; ALPROSTADIL; ANGIOTENSIN II; ANIMALS; ARTERIES; DINOPROSTONE; DRUG COMBINATIONS; EAR; ELECTRIC STIMULATION; HUMANS; HYPERTENSION; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; NOREPINEPHRINE; PERFUSION; RABBITS; SYMPATHETIC NERVOUS SYSTEM; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0036626018     PISSN: 09168737     EISSN: None     Source Type: Journal    
DOI: 10.1540/jsmr.38.51     Document Type: Article

References (44)

1. Aviado, D.M. (1971). Ganglionic stimulant and blocking drugs. In: Drill's Pharmacology In Medicine, ed. by J.R. Dipalma, McGraw-Hill Book Company, New York, pp. 708-731.
2. Bergström, S. (1967). Prostaglandins: Members of a new hormonal system. These physiologically very potent compounds of ubiquitous occurrence are formed from essential fatty acids. Science 157: 382-391.
3. Boehm, S. and Kubista, H. (2002). Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors. Pharmacol. Rev. 54: 43-99.
4. Brunner, H.R., Laragh, J.H., Baer, L., Newton, M.A., Goodwin, F.T., Krakoff, L.R., Bard, R.H. and Buhler, F.R. (1972). Essential hypertension: Renin and aldosterone, heart attack and stroke. N. Engl. J. Med. 286: 441-449.
5. Cockcroft, J.R., Chowienczyk, P.J., Benjamin, N. and Ritter, J.M. (1994). Preserved endothelium-dependent vasodilation in patients with essential hypertension. N. Engl. J. Med. 330: 1036-1040.
6. de la Lande, I.S., Paton, W.D.S. and Waud, B. (1968). Output of sympathetic transmitter in the isolated rabbit ear. Aust. J. Exp. Biol. Med. Sci. 46: 727-738.
7. Doyle, A.E. and Fraser, J.R.E. (1961). Vascular reactivity in hypertension. Circ. Res. 9: 755-758.
8. Eich, R.H., Cuddy, R.P., Smulyan, H. and Lyon R.H. (1966). Hemodynamics in labile hypertension. A follow-up study. Circulation 34: 299-307.
9. Frohlich, E.D., Dustan, H.P. and Page, I.H. (1966). Hyperdynamic beta-adrenergic circulatory state. Arch. Intern. Med. 117: 614-619.
10. Guimaraes, S., Paiva, M.Q. and Moura, D. (1998). Different receptors for angiotensin II at pre- and postjunctional level of the canine mesentertic and pulmonary arteries. Br. J. Pharmacol. 124: 1207-1212.
11. 2 on sympathetic neurotransmission in the cat spleen. Acta Physiol. Scand. 80: 269-275.
12. Hickler, R.B., Hamlin, J.T. and Wells, R.E. (1959). Plasma norpinephrine response to tilting in essential hypertension. Circulation 20: 422-426.
13. Hollenberg, N.K., Epstein, M, Basch, R.I. and Merril J.P. (1969). "No man's land" of the renal vasculature. An arteriographic and hemodynamic assessment of the interlobar and arcuate arteries in essential and accelerated hypertension. Am. J. Med. 47: 845-854.
14. Jensen, T.J. and Nedergaard, O.A. (1999). Modulation of norepinephrine release from sympathetic neurons of the rabbit aorta by prejunctional prostanoid receptors. J. Pharmacol. Exp. Ther. 291: 7-11.
15. John, S.W.M., Krege, J.H., Oliver, P.M., Hagaman, J.R., Hodgin, J.B., Pang, S.C., Flynn, T.G. and Smithies, O. (1995). Genetic decrease in atrial natriuretic peptide and salt-sesitive hypertension. Science 267: 679-681.
16. 1 on renal hemodynamics, sodium and water excretion. Am. J. Physiol. 213: 939-946.
17. Kohno, M., Yasunari, K., Murakawa, K.-I., Yokokawa, K., Horio, T., Fukui, T. and Takeda, T. (1990). Plasma immunoreactive endothelin level in patients with essential hypertension. Am. J. Med. 88: 614-618.
18. 1 on cerebral mechanisms involved in the control of fluid balance. Acta Physiol. Scand. 98: 85-93.
19. Lowenstein, J., Steinmetz, P.R., Effros, R.M., Demeester, M., Chasis, H. and Baldwin, D.S. (1967). The distribution of intrarenal blood flow in normal and hypertensive man. Circulation 35: 250-259.
20. Maggi, F.M., Maddox, Y., Karanian, J., Tyrrell, N., Ramey, E.R. and Ramwell, P.W. (1981). Gender differences in arachidonate metabolism. In: Atherosclerosis Vol. 8, ed. by R.J. Hegyeli, Raven Press, New York, pp. 159-165.
21. Malik, K.U. and Lung, G.M. (1975). Modification by prostaglandins of adrenergic transmisstion in the isolated perfused rabbit and rat kidney. Circ. Res. 36: 599-609.
22. 2, indomethacin and arachidonic acid of the vasoconstrictor responses of the isorated perfused rabbit and rat mesenteric arteries to adrenergic stimuli. Circ. Res. 39: 163-168.
23. Mendlowitz, M. (1967). Vascular reactivity in essential and renal hypertension in man. Am. Heart J. 73: 121-128.
24. 1 on smooth muscle contraction and calcium responses. Prostaglandins 15: 803-812.
25. Michibayashi, T. (1980). Prostaglandins A and E levels in human essential hypertention. Adv. Prostaglandin Thromboxane Res. 7: 791-796.
26. Michibayashi, T., Takada, M. and Hisada, N. (1981). Responsiveness of peripheral vascular resistance to noradrenaline and prostaglandin E - With special reference to endogenous prostaglandin E in the vascular beds. J. Jap. Coll. Angiol. 21: 255-262.
27. Michibayashi, T. (1985). Interaction between angiotensin II and prostaglandin E on the perivascular sympathetic nerve activity. J. Jap. Coll. Angiol. 25: 1247-1253.
28. 2. J. Smooth Muscle Res. 28: 25-33.
29. Nekrasova, A.A., Sokolova, R.N., Levitskaya, Yu., Speranskaya, N.V., Kulagina, V.P. and Leghonkaya, N.P. (1980). Prostaglandins of blood vessels and vessel reactivity in rats receiving sodium chloride and indomethacin. Adv. Prostaglandins Thromboxane Res. 7: 1139-1143.
30. Nestel, P.J. (1969). Blood-pressure and catecholamine excretion after mental stress in labile hypertension. Lancet I: 692-694.
31. Panza J.A., Quyyumi, A.A., Brush, J.E. and Epstein, S.E. (1990). Abnormal endothelium-dependent relaxation in patients with essential hypertention. N. Engl. J. Med. 323: 22-27.
32. Papanicolaou, N., Mountokalakis, T., Safar, M., Bariety, J. and Milliez, P. (1976). Deficiency in renomedullary prostaglandin synthesis related to the evolution of essential hypertension. Experientia 32: 1015-1017.
33. Redgrave, J., Rabinowe, S., Hollenberg, N.K. and Williams, G.H. (1985). Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertention. J. Clin. Invest. 75: 1285-1290.
34. Rump, L.C., Bohmann, C. and Schaible, U. (1995). Beta 2-adrenergic, angiotensin II and bradykinin receptors enhance neurotransmission in human kidney. Hypertension 26: 445-451.
35. Sannerstedt, R. (1966). Hemodynamic response to exercise in patients with arterial hypertension. Acta Med. Scand. 180 (Suppl 458): 1-70.
36. Shichiri, M., Hirata, Y., Ando, K., Emori, T., Ohta, K., Kimoto, S., Ogura, M., Inoue, A. and Marumo, F. (1990). Plasma endothelin levels in hypertension and choronic renal failure. Hypertension 15: 493-496.
37. 2 on noradrenaline secretion from sympathetic nerves as a function of external calcium. Prostaglandins 3: 105-109.
38. 1 mediated control. Acta Physiol. Scand. 101: 199-210.
39. Stjärne, L. and Gripe, K. (1973). Prostaglandin-dependent and -independent feedback control of noradrenaline secretion in vasoconstrictor nerves of normotensive human subjects. Naunyn-Schmiedeberg's Arch. Pharmacol. 280: 441-446.
40. Stokes, J.B. (1983). Tubular actions of arachidonic acid metabolites. Effects on NaCl and water transport. In: Prostaglandins and the Kidney, ed. by M.J. Dunn, C. Patrono, G.A. Cinotti, New York and London, Medical Book Company, pp 133-149.
41. Storgaard, T. and Nedergaard, O.A. (1997). Prejunctional modulation by angiotensins of noradrenaline release from sympathetic neurons in isolated rabbit aorta. Naunyn-Schmiedeberg's Arch. Pharmacol. 356: 706-711.
42. 1α on isolated vascular smooth muscle. Am. J. Physiol. 213: 725-733.
43. 2: A newly identified lesion. Prostaglandins 15: 139-150.
44. Uchida, E. and Bohr, D.F. (1969). Myogenic tone in isolated perfused resistence vessels from rats. Am. J. Physiol. 216: 1343-1350.